Darja Jereb

Title: Darja Jereb: Innovator in Pharmaceutical Chemistry

Introduction

Darja Jereb is a notable inventor based in Radomlje, Slovenia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds. With a total of 2 patents, his work has implications for the development of effective medications.

Latest Patents

Darja Jereb's latest patents include a process for the synthesis of 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfiny-1H-benzimidazole. This innovative method involves the oxidation of a specific thio compound with 3-chloroperoxy-benzoic acid in ethyl acetate, optimizing conditions for solubility and yield. His second patent describes a new process for preparing ceftriaxon disodium salt hemiheptahydrate, a third-generation cephalosporin antibiotic. This process utilizes a reactive acetic acid derivative in a controlled temperature environment to achieve high purity and yield of the desired compound.

Career Highlights

Throughout his career, Darja Jereb has worked with prominent companies in the pharmaceutical industry, including Lek and Tovarna Farmacevtskih in Kemicnih Izdelkov. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug synthesis.

Collaborations

Darja has collaborated with several professionals in his field, including Natasa Hafner Milac and Natasa H Milac. These partnerships have fostered a collaborative environment that enhances innovation and research in pharmaceutical chemistry.

Conclusion

Darja Jereb's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence the development of essential medications, showcasing the importance of innovation in healthcare.